As reported by the Financial Times, Volkswagen is currently in talks with Rafael Advanced Defense Systems to establish cooperation related to military production. At stake is the potential rescue of one of the company’s Saxon plants, which is threatened with closure.
The deal is expected to involve converting the facility into a plant producing components for Israel’s “Iron Dome” defense system. VW’s factory in Osnabrück currently employs ~2,300 people. The group is facing growing difficulties in maintaining employment levels, and given the company’s capabilities and expertise, a potential order could come from Israel, which is currently struggling with shortages of rocket ammunition and support systems.
This is a small but noteworthy “consolation” for the company’s employees. The company’s estimates and forecasts assume a further reduction in headcount by another 30,000–50,000 by the end of 2030. At the end of 2024, the company’s workforce, excluding plants in China, amounted to 614,000 people, of whom 293,000 positions were located in Germany.
This is not the first initiative in the defense market in recent quarters—several months ago the company received a significant truck order from the German armed forces.
VWOV1.DE (D1)
The company’s shares are reacting with a small bullish gap to the news about the potential deal. The price is breaking above the key €89–90 per share level; however, it still remains near the lower boundary of the long-term upward trend. Source: xStation5.
What else might we be missing from the Persian Gulf❓
What’s next for Iran?
Trump drops Iran ultimatum 🚨 TACO turns the markets around 📈
Central Banks in the Grip of an Oil Shock: Hawkish BoJ and Defensive Rate Decisions in Europe
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
